Abstract: Neurological sequelae including gait impairment were reported in survivors after methanol intoxication; however, no systematic study has been published so far. We aimed to analyse gait and balance impairment in a group of Czech methanol poisoning survivors. We examined 43 patients (age 46 AE 13 years) 2-8 months after methanol poisoning and 43 healthy controls. Investigations contained a shortened version of Falls Efficacy Scale (FES), clinical tests of gait and balance including Timed Up and Go test (TUG) and gait analysis using GaitRite â system, neurological and neuropsychological examination, brain imaging, EMG and tests of alcohol consumption. Nineteen patients admitted balance and gait impairment according to FES. Mild to moderate parkinsonian signs showed seven patients. Patients were slower (8.8 versus 5.7 s, p < 0.001) and performed more steps (11.1 versus 7.9, p < 0.001) in TUG compared with the controls. Gait analysis revealed shorter step length (76.5 versus 88.7 cm, p < 0.001), increased double support phase (18.8 versus 15.5%, p < 0.001) and wider base of support (11.3 versus 9.6 cm, p = 0.006) in patients. Eleven patients had deficit of executive function and performed higher cadence compared to the patients with normal execution (122.7 versus 115.0 step/min., p = 0.025). Lower limb polyneuropathy was verified in nine patients, without relation with gait or balance parameters. Neuroimaging revealed lesions mainly in the basal ganglia. Methanol poisoning survivors presented slower wide-based gait with shortened steps corresponding with frontal gait disorder. Higher stepping cadence associated with executive deficit supported the evidence of frontal lobe dysfunction related to impairment of basal ganglia and connections in frontal cortico-basal ganglia loops.
Methanol is a colourless liquid, resembling ethanol in smell and taste. Intoxications occur as isolated accidental episodes or as a mass or cluster poisonings due to consumption of illicit adulterated spirits [1] [2] [3] . In the Czech Republic, it was a rare condition until a mass poisoning outbreak in 2012-2014 with 137 intoxicated patients due to ingestion of adulterated alcoholic beverages [4, 5] . The mortality and the prevalence of health sequelae in survivors were high despite efficient treatment [6] [7] [8] [9] .
Absorption of methanol after oral administration is rapid with the attainment of peak methanol concentrations within 30-60 min. after ingestion. The minimal lethal dose of ingested methanol in adults is about 1 mg/kg of body-weight; however, the toxicity of methanol itself is relatively low. The products of biotransformation in the liver (formaldehyde and formic acid) in combination with metabolic acidosis are responsible for the major toxic effects in human beings [10] [11] [12] . The severity of clinical symptoms also depends on the concomitant amount of ingested ethanol due to competitive inhibition along the metabolic pathway [13, 14] .
Acute symptoms of methanol intoxication usually develop after initial inebriety. The main complaints are headache, nausea, epigastric pain or vomiting. After a latent period of 12-24 hr may appear visual disturbances, epileptic seizures or even rapid deterioration to stupor, coma and sudden death in some cases [2, 10] . Biochemical analysis proves severe metabolic acidosis with high osmotic gap, increased pCO2 and high S-formate and S-lactate levels [12] .
Late-term neurological and visual symptoms occur in survivors with delay of days up to weeks after intoxication [15, 16] . Parkinsonism [17] , pyramidal signs [18] , gait disorders [19] [20] [21] [22] [23] and seldom dystonia [19, 24, 25] were described in previous studies. Neuroimaging findings can reveal structural damage of the basal ganglia with predominant affection of putamen [26] . Symmetrical bilateral putaminal lesions range from partial changes to all-embracing haemorrhagic necrosis [20, [26] [27] [28] and are supposed to be caused by the predilect accumulation of formic acid in high concentrations within the putamen; however, the reasons for this phenomenon are unclear [26] . A direct toxic effect of formic acid due to the inhibition of cytochrome c oxidase is also considered [29] . A reduction in the blood flow through the basal veins of Rosenthal upon secondary hypotension during intoxication [27] may also have a key role in affection of basal ganglia and the optic nerve, which are susceptible to anoxia and metabolic acidosis [30] . Others propose that formic acid is able to increase enzymatic activity of dopa-B-hydroxylase and impair dopaminergic pathway [31] . Secondary myeloclastic effect of accumulated formic acid within the optic nerve leads to visual disturbances [32] . Among other findings are [20, 26, 27] occasionally lesions in caudate nucleus, brainstem or cerebellar area [33, 34] or subcortical white matter lesions.
No systematic study of gait disorders after methanol intoxication has been published so far, although several papers mentioned gait impairment with a parkinsonian pattern, characterized as slow shuffling [19] , with stooped flexed posture [20] , reduced arm swing [21] , small steps and impaired balance [22] . Others reported broad-based propulsive gait [35] with difficulty in initiating movement. Hesitation [20] and festination [23] were seen in a few cases. Ataxic (unstable) gait with worsening after exclusion of visual control and sensory loss on the distal part of the legs was described in patients in Estonia [32] .
The primary aim of our study was to analyse the gait and balance disturbances in a group of survivors after acute methanol poisoning. Considering the previous reports, we suggested that prevailing gait pattern will be characterized by parkinsonian features. We further aimed to evaluate the severity of gait impairment and to correlate gait parameters to other clinical findings in our group of patients.
Patients and methods
The study was approved by the General University Hospital Ethics Committee and was in compliance with the Declaration of Helsinki.
Participation in the study was offered to all 83 survivors from a total of 137 patients, who were poisoned by methanol during the mass outbreak between September 2012 and January 2014 in the Czech Republic [36] . Fifty patients agreed to take a part in the study; however, we had to exclude seven of them due to inability to walk independently, blindness, hemiparesis after previous stroke or refusal to complete the examination. We included 43 patients (nine females, 34 males; mean age 46 AE 13 years, ranged 24-73 years) about 2-8 months after the proven acute methanol intoxication. A detailed record of history of the poisoning and acute care facility data were collected and analysed centrally in the Czech Toxicological Information Center [4] ; for more detail, see table 1.
A healthy control group consisted of 43 age-and sex-matched volunteers (nine females, 34 males; mean age 46 AE 13 years, ranged 24-73; p = 0.484), who were free of any neurological, psychiatric or other disabling illness. All controls denied intake of any medication acting on the central nervous system, and only occasional alcohol consumption was referred, not fulfilling the criteria of harmful use.
Neither patients nor controls were under alcohol influence during the examination. No participant had a severe rheumatic or orthopaedic disease, trauma, congenital malformation of lower extremities or other illness interfering with gait.
All patients filled in a shortened version of the Falls Efficacy ScaleInternational (FES-I, score range 77-28, cut-off 8), which contains seven simple questions concerning instability and fear of falling in usual daily activities [37] . Neurological symptoms in patients were rated by the Natural History and Neuroprotection in Parkinson Plus Syndromes -Parkinson Plus Scale (NNIPPS-PPS, ranging from 0 to 335 points), which evaluates signs of parkinsonism as well as dystonic, cerebellar, pyramidal features, myoclonus, bulbar/pseudobulbar, orthostatic and urinary symptoms [38] . The Mini-Mental State Exam (MMSE, score range 0-30, cut-off 24) was used to assess cognitive state [39] , the Frontal Assessment Battery to evaluate frontal lobe function (FAB, score range 0-18, cut-off <16 was used to define executive impairment) [40] and the Digit Span Backwards for measuring verbal working memory ability. Tests of executive function targeted on initiation (Controlled Oral Word Association Test, COWAT) [41] , set shifting (Trail Making Test -part B, TMT-B) [42] and inhibition (Stroop Interference) [43] .
All participants underwent a set of clinical tests focusing on gait and balance. The Timed Up and Go test (TUG) was used to assess functional mobility. The examination includes rising from a chair, walking 3 m forward, 180°turning and walking back to the chair to sit down [44] . The number of steps and time needed to complete the examination were recorded.
Postural stability was evaluated by the pull test [45] that measures the ability to recover from a backward pull to the shoulders. The test is rated as normal if the subject recovers independently and may take 1 or 2 steps or an ankle reaction. Abnormal results of the test included three or more steps backward to recover or the need to be assisted to prevent falling.
The Romberg test [46] was performed to examine static standing balance. The subject stands with feet together with eyes open and then closed for 20 sec. Inability to maintain the position after removing visual input indicates sensory impairment [47] .
The Functional Reach Test (FRT) [48] assesses stability by measuring the maximum distance an individual can reach forward while standing in a fixed position. The distance was calculated as a difference between the primary and the final position of the fist at the 3rd metacarpal head.
The 360 Degree Turn Test (360°Turn) [49] evaluates dynamic balance. The subject performed a complete circle (360 degrees) in comfortable and fast speed clockwise and counterclockwise, while the time and the number of steps to complete the turn were recorded.
To provide a more detailed temporo-spatial analysis of gait pattern, we used the GaitRite Analysis System. It consists of a 4.6-m-long computerized pressure-sensitive walking mat, covered by sensors, which are arranged in a grid-like pattern to identify footfall contacts. All participants were instructed to walk over the mat at comfortable preferred speed, fast walking speed and with eyes closed at preferred speed. All gait examinations were repeated twice. We gathered spatial (step length, base width) and temporal characteristics (step time, double support time, gait velocity and cadence) of the gait of both investigated groups. (For details of the gait parameters see Appendix S1).
A magnetic resonance investigation of the brain (MRI, Gyroscan Philips 1.5 T with the following protocol: axial T2-weighted image, fluid-attenuated inversion recovery, pre-and post-contrast T1-weighted image and spectral pre-saturation with inversion recovery coronal images centred to the orbital region), was performed in all patients Table 1 . Admission laboratory and clinical parameters of acute methanol poisoning in 43 patients.
Median (IQR)
Min-max S-MetOH, serum methanol concentration; S-EtOH, serum ethanol concentration; S-lactate, serum lactate concentration; GCS, Glasgow Coma Scale; S, serum. except three, who had a computed tomography (CT, native scans) due to contraindications for MRI. The Alcohol Use Disorders Identification Test (AUDIT; range 0-36, cut-off 7) was used as a screening questionnaire of alcohol consumption [50] in patients, because risk drinking of alcohol was reported in discharge reports at the time of methanol intoxication in 26 (60%) patients. Each patient underwent an alcohol breath test and a set of laboratory examinations including ethyl glucuronide in urine (EthGlu, positive/negative detection in urine), carbohydrate-deficient transferrin (CDT, normal range 0%-2%) and gamma-glutamyltransferase (GGT, normal range 0.1-0.7 lkat/l) for objective evaluation. Electromyography (EMG) of lower limbs was performed in patients to measure nerve conduction velocity in search of possible neuropathy.
Descriptive statistics for the collected data was performed to determine the distribution of demographic, clinical and gait variables. Gait parameters were calculated as an arithmetic mean value of results in two trials in each condition. Intergroup differences in methanol and control group were assessed using a two-sample t-test (for parameters with a normal distribution according to Shapiro-Wilk test) or the Mann-Whitney and Wilcoxon rank-sum test (for non-normally distributed parameters). To evaluate the influence of leg length on gait parameters, an analysis of covariance (ANCOVA) was performed (with leg length as covariates); similarly, ANCOVA was used in comparison of results of AUDIT to exclude the influence of age. Pearson's chisquared test and Spearman tests were performed to assess correlations between variables (i.e. biochemical parameters, GCS, neuropsychological tests, FES, NNIPPS and gait parameters) and intergroup differences in methanol patients with abnormal findings on MRI and EMG; executive tests were assessed by the Mann-Whitney test.
Results
In the neurological examination as reflected by NNIPPS-PPS, we did not find clinically relevant group abnormalities in any subdomain. Seven patients (16%) fulfilled the criteria of parkinsonism (presence of bradykinesia with either rigidity or tremor resulting in combined NNIPPS subscore >4) corresponding to mild (subscore 5-10) to moderate (subscore 11-20) parkinsonism severity. Cerebellar features found in 16 (37%) subjects were only of minimal severity according to NNIPPS (cerebellar subscore ranged 1-6). Nineteen patients (44%) admitted subjective balance and gait impairment with FES total score ranging from 9 to 24. MMSE was within normal range except in three patients (7%). FAB demonstrated impaired frontal functions in 16 patients (37%). Executive deficit (based on performance score below 1.5 S.D. from normal mean in at least two executive tests including TMT-B, COWAT, Digit Span Backwards and Stroop Interference) was documented in 11 patients (26%). Results are presented in table 2.
Gait and balance parameters of methanol survivors and control group are summarized in table 3. In the TUG test, the patients were clearly slower and walked with greater cadence compared with the control group (both p < 0.001). From the measures obtained using the GaitRite system, gait velocities at a comfortable pace were similar in both groups; however, the patients showed greater cadence than controls (p = 0.002), but their increased cadence at a fast gait speed was significantly lower than in controls. In the fast speed condition, the patients produced a significantly shorter step length and a higher step time and had lower velocity and a clearly longer duration of the double support phase of gait cycle in comparison with the controls (all p < 0.001). The base of support was wider in the patients, especially in comfortable pace of walking (p=0.006), and further widened while walking with closed eyes (p = 0.022). The methanol group was also slower in fast turning (p < 0.001) and achieved shorter distance in FRT (p < 0.001). Only two patients (5%) had difficulties in the Romberg test and six patients [14] scored abnormal at the pull test.
The patients with executive impairment (N = 11) had a significantly higher cadence in comfortable gait compared to patients (N = 32) with normal executive function (122.7 versus 115.0 step/min., Z À2,236, p = 0.025). No significant correlations were found between gait parameters and NNIPPS-PPS, FES, MMSE, FAB score. We also did not prove significant correlations between measured gait parameters and admission laboratory parameters obtained at the acute care facility during hospitalization.
Positive screening of the harmful use of alcohol according to AUDIT was present in 22 of the methanol patients (51%). The alcohol breath test was negative in all participants during the examination, EthGlu in urines was positive in 26 (61%), elevated serum CDT was observed in 14 (33%), and increased levels of GGT were found in 16 (37%) patients. Patients with positive screening according to AUDIT were significantly younger (41.2 AE 11.9 versus 53.4 AE 13.3 years, p = 0.004) and showed no significant differences in gait or balance measures compared to patients with negative screening if effect of age was eliminated. Interestingly, we found a higher gait velocity at a comfortable pace in patients with positive screening of CDT (1.59 AE 0.23 versus 1.38 AE 0.21 m/sec., p ≤ 0.01) and EthGlu (1.52 AE 0.25 versus 1.32 AE 0.16 m/ sec., p ≤ 0.01). Even so, we failed to prove any significant correlation between serum and urines biochemical parameters and the results of gait or balance tests.
EMG verified distal lower limb polyneuropathy was only mild. Patients with positive finding on EMG were of higher age compared to those with negative findings (58.4 AE 11.3 versus 42.0 AE 12.1 years, p < 0.001); however, no significant differences in gait parameters were observed in comparison with the other patients.
Neuroimaging of brain revealed lesions mainly in the basal, including bilateral putaminal necrosis and/or lesions in the pallidum, rarely in the brainstem, cerebellum and subcortical white matter (more details in table 2).
Discussion
In the current study, we attempted to confirm the hypothesis that patients after methanol intoxication suffer from parkinsonian gait impairment as suggested in previous studies [19] [20] [21] [22] [23] . Indeed, the group analysis of gait measures revealed shorter steps and lower velocity in fast speed with inability to adapt length and duration of the steps to gain appropriate speed in methanol patients compared with the healthy individuals. Those characteristics are, however, not specific only for parkinsonian gait. In the clinical assessment, we did not observe other typical parkinsonian features, such as stooped flexed posture, reduced arm swing, freezing, hesitation [20] or propulsive gait [35] . In fact, except of seven subjects, the majority of the patients lacked any considerable signs of parkinsonism in the neurological examination scored by NNIPPS-PPS.
The results of gait analysis support alternative interpretation of the further differences between the methanol group and the healthy controls [51] . Namely, a wider base of support at a comfortable gait speed can be present in cerebellar ataxia [52, 53] , vestibular disorder [54] or impairment of proprioception [55] . However, we did not observe clinically relevant features of cerebellar involvement or vestibular disorder either in neurological examination or according to NNIPPS-PPS subscores. The neuroimaging findings were also unsupportive as only one patient had a cerebellar lesion and one a marked cerebellar atrophy. Sensory ataxia could be considered, based on the detection of wide-based gait that further deteriorated when patients walked with eyes closed; nevertheless, distal sensory polyneuropathy was verified by EMG only in onefifth of the patients, and its presence did not show any relation to gait or balance parameters.
All the evidence leads us to suppose that the gait pattern revealed by gait analysis in methanol patients corresponds with frontal gait disorder [56] , a higher-level gait disorder [57, 58] , known also under terms including gait apraxia [59, 60] , lower body parkinsonism [61] , marche a petits pas or vascular parkinsonism [62] . Frontal gait disorder has typically been described as slower wide-based gait with shortened steps accompanied by postural instability and fear of falling, with normal voluntary movements of the upper limbs, and the absence of a rest tremor [63] . In the patients, most of these features were documented in comparison with the healthy control group. Slower gait compared with controls was shown in (40) 23 (53%) 1.0 (0.0-3.5) (0-10) Bulbar-pseudobulbar signs (24) 12 ( both TUG and a computerized gait analysis at fast speed of walking. The analysis revealed wider base of support, shorter steps and higher cadence of stepping in methanol patients. The ability to increase walking speed by increasing the cadence of stepping is typically impaired in frontal gait disorder [58] , while it remains preserved in Parkinson's disease [64] . Moreover, documented fear of falling with increased FES scores together with slower turning and worse performance in FRT reflects a compromised static and dynamic balance in methanol patients compared with the control group. The estimated presence of frontal gait disorder in the patients is further supported by the documented impairment of other frontal functions. Cognitive deficit of the frontal type in patients after acute methanol poisoning was documented in previous works [15] . In accordance with those results, we proved a cognitive decline according to FAB and particularly executive impairment, correlating with a higher cadence in comfortable gait. Executive dysfunction has previously been reported in connection with difficulty in maintaining walking stability and an elevated fall risk [65] [66] [67] , typically accompanying the frontal gait disorder [63] .
Frontal gait disorder reflects disrupted connections in the cortico-basal ganglia loops [57] . Neuroimaging studies in general fail to define a specific related pathology and describe rather non-specific findings such as diffuse subcortical white matter changes that may be associated with the so-called vascular parkinsonism as well as with gait and balance abnormalities in non-disabled elderly [62, 68] . Conversely, typical MRI findings after methanol intoxication show structural damage of the basal ganglia [20, 26, 27] that was also demonstrated in one-third of the patients, including mainly bilateral putaminal necrosis and lesions in the pallidum [61, 62] . However, we failed to find a statistically significant association between imaging findings and gait parameters in our group of patients. The explanation could be in a mostly subclinical impairment in the patients, which was detectable only on a detailed gait analysis, with no evident clinical manifestation of a movement disorder during the standard neurological examination.
The major limitation of our study is the fact that we could not investigate the most affected subjects due to high mortality of the methanol poisoning or inability to walk independently in the severely affected subjects. Secondly, without controls with an appropriate history of alcohol consumption, we cannot clearly exclude the effects of chronic ethanol consumption in the patients, despite the absent relevant correlations between the gait parameters and the biochemistry or EMG findings. In the further research, it will be appropriate to evaluate the development of the proven deficit over time in a prospective study.
Conclusion
Survivors of methanol poisoning did not present a typical parkinsonian gait pattern. Compared with the healthy controls, the patients presented slower wide-based gait with shortened steps that correspond to the pattern of frontal gait disorder. Higher stepping cadence associated with executive dysfunction supports the evidence of frontal lobe dysfunction related to the basal ganglia dysfunction and disrupted connections in the frontal cortico-basal ganglia loops as the sequelae of methanol poisoning. Values are mean AE S.D. (n = 43). *p < 0.05, **p < 0.01, ***p < 0.001, ANCOVA compared with healthy controls.
